エリスロポエチン製剤の世界市場

【英語タイトル】Erythropoietin Drug - Global Market Outlook (2016-2022)

Stratistics MRCが出版した調査資料(SMRC70523041)・商品コード:SMRC70523041
・発行会社(調査会社):Stratistics MRC
・発行日:2017年2月
・ページ数:132
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥452,350見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥572,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥817,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、エリスロポエチン製剤の世界市場について調査・分析し、エリスロポエチン製剤の世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
- エグゼクティブサマリー
- 序文
- エリスロポエチン製剤の世界市場:市場動向分析
- エリスロポエチン製剤の世界市場:競争要因分析
- エリスロポエチン製剤の世界市場:製品別
・バイオシミラー
・生物製剤
- エリスロポエチン製剤の世界市場:製剤別
・バイオシミラー製剤
・生物製剤
- エリスロポエチン製剤の世界市場:用途別
・貧血
・HIV
・末期の腎疾患
・癌
・透析
・腫瘍
・その他
- エリスロポエチン製剤の世界市場:エンドユーザー別
・小売薬局
・病院
・その他
- エリスロポエチン製剤の世界市場:主要地域別分析
- エリスロポエチン製剤の北米市場規模(アメリカ市場等)
- エリスロポエチン製剤のヨーロッパ市場規模
- エリスロポエチン製剤のアジア市場規模(日本市場、中国市場、インド市場等)
・エリスロポエチン製剤の世界市場:主な市場開拓
- 関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Erythropoietin Drug Market is accounted for $8.04 billion in 2016 and is expected to reach $14.4 billion by 2022 growing at a CAGR of 10.2% from 2016 to 2022. Rising number of chronic kidney diseases (CKD) and dialysis patient pools are the major drivers for the market. Moreover, increasing cases of cancer, HIV‘s and ESRD (End Stage Renal Diseases) are some of the factors enhancing the market growth. However, growing competition from substitute drugs and rising threats from thrombosis and PRCA are the factors inhibiting the market size.

By Application, anemia segment leads the Erythropoietin Drugs market during the forecast period. On the other hand, retail pharmacies in end user segment dominated the global market with a huge market share. In terms of geography, Europe commanded the maximum market share and will continue to dominate the market over the forecast period.

Some of the key players in the market include Johnson and Johnson, Hospira, Inc., F. Hoffmann-La Roche AG, Amgen Inc, Kyowa Hakko Kirin Co., Ltd, 3SBio Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Intas Pharmaceuticals, Dr. Reddy’s Laboratories, Teva Pharmaceutical Industries, JCR Pharmaceuticals, LG Life Science, Novartis AG, Shenyang Sunshine Pharmaceutical, Sihuan Pharmaceutical, Uni-Bio Science, Wanbang Biochemical Pharmaceuticals, Pfizer Inc., Chugai Pharmaceutical and Dragon Pharma.

Products Covered:
• Biosimilars
o Epoetin-Alfa
o Epoetin-Beta
o Darbepoietin-Alfa
o Other Biosimilar Products
• Biologics
o Epoetin-Zeta
o Epoetin-Omega
• Other Biologic Products

Drugs Covered:
• Biosimilar Drug
o Xue Da Sheng
o HEMAX
o Abseamed
o Retacrit
o Epoetin-alfa BS
o EPIAO
o Binocrit
o Other Biosimilar Drugs
• Biologic Drug
o Aranesp
o Mircera
o Procrit
o NeoRecromon
o Eprex
o Epogen
o Other Biologic Drugs

Applications Covered:
• Anemia
• HIV
• End Stage Renal Disease
• Cancer
• Dialysis
• Oncology Diseases
• Other Applications

End Users Covered:
• Retail Pharmacies
• Hospital
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
4.0 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Erythropoietin Drug Market, By Product
5.1 Introduction
5.2 Biosimilars
5.2.1 Epoetin-Alfa
5.2.2 Epoetin-Beta
5.2.3 Darbepoietin-Alfa
5.2.4 Other Biosimilar Products
5.3 Biologics
5.3.1 Epoetin-Zeta
5.3.2 Epoetin-Omega
5.3.3 Other Biologic Products

6 Global Erythropoietin Drug Market, By Drug
6.1 Introduction
6.2 Biosimilar Drug
6.2.1 Xue Da Sheng
6.2.2 HEMAX
6.2.3 Abseamed
6.2.4 Retacrit
6.2.5 Epoetin-alfa BS
6.2.6 EPIAO
6.2.7 Binocrit
6.2.8 Other Biosimilar Drugs
6.3 Biologic Drug
6.3.1 Aranesp
6.3.2 Mircera
6.3.3 Procrit
6.3.4 NeoRecromon
6.3.5 Eprex
6.3.6 Epogen
6.3.7 Other Biologic Drugs

7 Global Erythropoietin Drug Market, By Application
7.1 Introduction
7.2 Anemia
7.3 HIV
7.4 End Stage Renal Disease
7.5 Cancer
7.6 Dialysis
7.7 Oncology Diseases
7.8 Other Applications

8 Global Erythropoietin Drug Market, By End User
8.1 Introduction
8.2 Retail Pharmacies
8.3 Hospital
8.4 Other End Users

9 Global Erythropoietin Drug Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Johnson and Johnson
11.2 Hospira, Inc.
11.3 F. Hoffmann-La Roche AG
11.4 Amgen Inc
11.5 Kyowa Hakko Kirin Co., Ltd
11.6 3SBio Inc.
11.7 Boehringer Ingelheim Pharmaceuticals, Inc.
11.8 Intas Pharmaceuticals
11.9 Dr. Reddy’s Laboratories
11.10 Teva Pharmaceutical Industries
11.11 JCR Pharmaceuticals
11.12 LG Life Science
11.13 Novartis AG
11.14 Shenyang Sunshine Pharmaceutical
11.15 Sihuan Pharmaceutical
11.16 Uni-Bio Science
11.17 Wanbang Biochemical Pharmaceuticals
11.18 Pfizer Inc.
11.19 Chugai Pharmaceutical
11.20 Dragon Pharma

List of Tables
Table 1 Global Erythropoietin Drug Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Erythropoietin Drug Market Outlook, By Product (2014-2022) ($MN)
Table 3 Global Erythropoietin Drug Market Outlook, By Biosimilars (2014-2022) ($MN)
Table 4 Global Erythropoietin Drug Market Outlook, By Epoetin-Alfa (2014-2022) ($MN)
Table 5 Global Erythropoietin Drug Market Outlook, By Epoetin-Beta (2014-2022) ($MN)
Table 6 Global Erythropoietin Drug Market Outlook, By Darbepoietin-Alfa (2014-2022) ($MN)
Table 7 Global Erythropoietin Drug Market Outlook, By Other Biosimilar Products (2014-2022) ($MN)
Table 8 Global Erythropoietin Drug Market Outlook, By Biologics (2014-2022) ($MN)
Table 9 Global Erythropoietin Drug Market Outlook, By Epoetin-Zeta (2014-2022) ($MN)
Table 10 Global Erythropoietin Drug Market Outlook, By Epoetin-Omega (2014-2022) ($MN)
Table 11 Global Erythropoietin Drug Market Outlook, By Other Biologic Products (2014-2022) ($MN)
Table 12 Global Erythropoietin Drug Market Outlook, By Drug (2014-2022) ($MN)
Table 13 Global Erythropoietin Drug Market Outlook, By Biosimilar Drug (2014-2022) ($MN)
Table 14 Global Erythropoietin Drug Market Outlook, By Xue Da Sheng (2014-2022) ($MN)
Table 15 Global Erythropoietin Drug Market Outlook, By HEMAX (2014-2022) ($MN)
Table 16 Global Erythropoietin Drug Market Outlook, By Abseamed (2014-2022) ($MN)
Table 17 Global Erythropoietin Drug Market Outlook, By Retacrit (2014-2022) ($MN)
Table 18 Global Erythropoietin Drug Market Outlook, By Epoetin-alfa BS (2014-2022) ($MN)
Table 19 Global Erythropoietin Drug Market Outlook, By EPIAO (2014-2022) ($MN)
Table 20 Global Erythropoietin Drug Market Outlook, By Binocrit (2014-2022) ($MN)
Table 21 Global Erythropoietin Drug Market Outlook, By Other Biosimilar Drugs (2014-2022) ($MN)
Table 22 Global Erythropoietin Drug Market Outlook, By Biologic Drug (2014-2022) ($MN)
Table 23 Global Erythropoietin Drug Market Outlook, By Aranesp (2014-2022) ($MN)
Table 24 Global Erythropoietin Drug Market Outlook, By Mircera (2014-2022) ($MN)
Table 25 Global Erythropoietin Drug Market Outlook, By Procrit (2014-2022) ($MN)
Table 26 Global Erythropoietin Drug Market Outlook, By NeoRecromon (2014-2022) ($MN)
Table 27 Global Erythropoietin Drug Market Outlook, By Eprex (2014-2022) ($MN)
Table 28 Global Erythropoietin Drug Market Outlook, By Epogen (2014-2022) ($MN)
Table 29 Global Erythropoietin Drug Market Outlook, By Other Biologic Durgs (2014-2022) ($MN)
Table 30 Global Erythropoietin Drug Market Outlook, By Application (2014-2022) ($MN)
Table 31 Global Erythropoietin Drug Market Outlook, By Anemia (2014-2022) ($MN)
Table 32 Global Erythropoietin Drug Market Outlook, By HIV (2014-2022) ($MN)
Table 33 Global Erythropoietin Drug Market Outlook, By End Stage Renal Disease (2014-2022) ($MN)
Table 34 Global Erythropoietin Drug Market Outlook, By Cancer (2014-2022) ($MN)
Table 35 Global Erythropoietin Drug Market Outlook, By Dialysis (2014-2022) ($MN)
Table 36 Global Erythropoietin Drug Market Outlook, By Oncology Diseases (2014-2022) ($MN)
Table 37 Global Erythropoietin Drug Market Outlook, By Other Applications (2014-2022) ($MN)
Table 38 Global Erythropoietin Drug Market Outlook, By End User (2014-2022) ($MN)
Table 39 Global Erythropoietin Drug Market Outlook, By Retail Pharmacies (2014-2022) ($MN)
Table 40 Global Erythropoietin Drug Market Outlook, By Hospital (2014-2022) ($MN)
Table 41 Global Erythropoietin Drug Market Outlook, By Other End Users (2014-2022) ($MN)
Table 42 North America Erythropoietin Drug Market Outlook, By Country (2014-2022) ($MN)
Table 43 North America Erythropoietin Drug Market Outlook, By Product (2014-2022) ($MN)
Table 44 North America Erythropoietin Drug Market Outlook, By Biosimilars (2014-2022) ($MN)
Table 45 North America Erythropoietin Drug Market Outlook, By Epoetin-Alfa (2014-2022) ($MN)
Table 46 North America Erythropoietin Drug Market Outlook, By Epoetin-Beta (2014-2022) ($MN)
Table 47 North America Erythropoietin Drug Market Outlook, By Darbepoietin-Alfa (2014-2022) ($MN)
Table 48 North America Erythropoietin Drug Market Outlook, By Other Biosimilar Products (2014-2022) ($MN)
Table 49 North America Erythropoietin Drug Market Outlook, By Biologics (2014-2022) ($MN)
Table 50 North America Erythropoietin Drug Market Outlook, By Epoetin-Zeta (2014-2022) ($MN)
Table 51 North America Erythropoietin Drug Market Outlook, By Epoetin-Omega (2014-2022) ($MN)
Table 52 North America Erythropoietin Drug Market Outlook, By Other Biologic Products (2014-2022) ($MN)
Table 53 North America Erythropoietin Drug Market Outlook, By Drug (2014-2022) ($MN)
Table 54 North America Erythropoietin Drug Market Outlook, By Biosimilar Drug (2014-2022) ($MN)
Table 55 North America Erythropoietin Drug Market Outlook, By Xue Da Sheng (2014-2022) ($MN)
Table 56 North America Erythropoietin Drug Market Outlook, By HEMAX (2014-2022) ($MN)
Table 57 North America Erythropoietin Drug Market Outlook, By Abseamed (2014-2022) ($MN)
Table 58 North America Erythropoietin Drug Market Outlook, By Retacrit (2014-2022) ($MN)
Table 59 North America Erythropoietin Drug Market Outlook, By Epoetin-alfa BS (2014-2022) ($MN)
Table 60 North America Erythropoietin Drug Market Outlook, By EPIAO (2014-2022) ($MN)
Table 61 North America Erythropoietin Drug Market Outlook, By Binocrit (2014-2022) ($MN)
Table 62 North America Erythropoietin Drug Market Outlook, By Other Biosimilar Drugs (2014-2022) ($MN)
Table 63 North America Erythropoietin Drug Market Outlook, By Biologic Drug (2014-2022) ($MN)
Table 64 North America Erythropoietin Drug Market Outlook, By Aranesp (2014-2022) ($MN)
Table 65 North America Erythropoietin Drug Market Outlook, By Mircera (2014-2022) ($MN)
Table 66 North America Erythropoietin Drug Market Outlook, By Procrit (2014-2022) ($MN)
Table 67 North America Erythropoietin Drug Market Outlook, By NeoRecromon (2014-2022) ($MN)
Table 68 North America Erythropoietin Drug Market Outlook, By Eprex (2014-2022) ($MN)
Table 69 North America Erythropoietin Drug Market Outlook, By Epogen (2014-2022) ($MN)
Table 70 North America Erythropoietin Drug Market Outlook, By Other Biologic Durgs (2014-2022) ($MN)
Table 71 North America Erythropoietin Drug Market Outlook, By Application (2014-2022) ($MN)
Table 72 North America Erythropoietin Drug Market Outlook, By Anemia (2014-2022) ($MN)
Table 73 North America Erythropoietin Drug Market Outlook, By HIV (2014-2022) ($MN)
Table 74 North America Erythropoietin Drug Market Outlook, By End Stage Renal Disease (2014-2022) ($MN)
Table 75 North America Erythropoietin Drug Market Outlook, By Cancer (2014-2022) ($MN)
Table 76 North America Erythropoietin Drug Market Outlook, By Dialysis (2014-2022) ($MN)
Table 77 North America Erythropoietin Drug Market Outlook, By Oncology Diseases (2014-2022) ($MN)
Table 78 North America Erythropoietin Drug Market Outlook, By Other Applications (2014-2022) ($MN)
Table 79 North America Erythropoietin Drug Market Outlook, By End User (2014-2022) ($MN)
Table 80 North America Erythropoietin Drug Market Outlook, By Retail Pharmacies (2014-2022) ($MN)
Table 81 North America Erythropoietin Drug Market Outlook, By Hospital (2014-2022) ($MN)
Table 82 North America Erythropoietin Drug Market Outlook, By Other End Users (2014-2022) ($MN)
Table 83 Europe Erythropoietin Drug Market Outlook, By Country (2014-2022) ($MN)
Table 84 Europe Erythropoietin Drug Market Outlook, By Product (2014-2022) ($MN)
Table 85 Europe Erythropoietin Drug Market Outlook, By Biosimilars (2014-2022) ($MN)
Table 86 Europe Erythropoietin Drug Market Outlook, By Epoetin-Alfa (2014-2022) ($MN)
Table 87 Europe Erythropoietin Drug Market Outlook, By Epoetin-Beta (2014-2022) ($MN)
Table 88 Europe Erythropoietin Drug Market Outlook, By Darbepoietin-Alfa (2014-2022) ($MN)
Table 89 Europe Erythropoietin Drug Market Outlook, By Other Biosimilar Products (2014-2022) ($MN)
Table 90 Europe Erythropoietin Drug Market Outlook, By Biologics (2014-2022) ($MN)
Table 91 Europe Erythropoietin Drug Market Outlook, By Epoetin-Zeta (2014-2022) ($MN)
Table 92 Europe Erythropoietin Drug Market Outlook, By Epoetin-Omega (2014-2022) ($MN)
Table 93 Europe Erythropoietin Drug Market Outlook, By Other Biologic Products (2014-2022) ($MN)
Table 94 Europe Erythropoietin Drug Market Outlook, By Drug (2014-2022) ($MN)
Table 95 Europe Erythropoietin Drug Market Outlook, By Biosimilar Drug (2014-2022) ($MN)
Table 96 Europe Erythropoietin Drug Market Outlook, By Xue Da Sheng (2014-2022) ($MN)
Table 97 Europe Erythropoietin Drug Market Outlook, By HEMAX (2014-2022) ($MN)
Table 98 Europe Erythropoietin Drug Market Outlook, By Abseamed (2014-2022) ($MN)
Table 99 Europe Erythropoietin Drug Market Outlook, By Retacrit (2014-2022) ($MN)
Table 100 Europe Erythropoietin Drug Market Outlook, By Epoetin-alfa BS (2014-2022) ($MN)
Table 101 Europe Erythropoietin Drug Market Outlook, By EPIAO (2014-2022) ($MN)
Table 102 Europe Erythropoietin Drug Market Outlook, By Binocrit (2014-2022) ($MN)
Table 103 Europe Erythropoietin Drug Market Outlook, By Other Biosimilar Drugs (2014-2022) ($MN)
Table 104 Europe Erythropoietin Drug Market Outlook, By Biologic Drug (2014-2022) ($MN)
Table 105 Europe Erythropoietin Drug Market Outlook, By Aranesp (2014-2022) ($MN)
Table 106 Europe Erythropoietin Drug Market Outlook, By Mircera (2014-2022) ($MN)
Table 107 Europe Erythropoietin Drug Market Outlook, By Procrit (2014-2022) ($MN)
Table 108 Europe Erythropoietin Drug Market Outlook, By NeoRecromon (2014-2022) ($MN)
Table 109 Europe Erythropoietin Drug Market Outlook, By Eprex (2014-2022) ($MN)
Table 110 Europe Erythropoietin Drug Market Outlook, By Epogen (2014-2022) ($MN)
Table 111 Europe Erythropoietin Drug Market Outlook, By Other Biologic Durgs (2014-2022) ($MN)
Table 112 Europe Erythropoietin Drug Market Outlook, By Application (2014-2022) ($MN)
Table 113 Europe Erythropoietin Drug Market Outlook, By Anemia (2014-2022) ($MN)
Table 114 Europe Erythropoietin Drug Market Outlook, By HIV (2014-2022) ($MN)
Table 115 Europe Erythropoietin Drug Market Outlook, By End Stage Renal Disease (2014-2022) ($MN)
Table 116 Europe Erythropoietin Drug Market Outlook, By Cancer (2014-2022) ($MN)
Table 117 Europe Erythropoietin Drug Market Outlook, By Dialysis (2014-2022) ($MN)
Table 118 Europe Erythropoietin Drug Market Outlook, By Oncology Diseases (2014-2022) ($MN)
Table 119 Europe Erythropoietin Drug Market Outlook, By Other Applications (2014-2022) ($MN)
Table 120 Europe Erythropoietin Drug Market Outlook, By End User (2014-2022) ($MN)
Table 121 Europe Erythropoietin Drug Market Outlook, By Retail Pharmacies (2014-2022) ($MN)
Table 122 Europe Erythropoietin Drug Market Outlook, By Hospital (2014-2022) ($MN)
Table 123 Europe Erythropoietin Drug Market Outlook, By Other End Users (2014-2022) ($MN)
Table 124 Asia Pacific Erythropoietin Drug Market Outlook, By Country (2014-2022) ($MN)
Table 125 Asia Pacific Erythropoietin Drug Market Outlook, By Product (2014-2022) ($MN)
Table 126 Asia Pacific Erythropoietin Drug Market Outlook, By Biosimilars (2014-2022) ($MN)
Table 127 Asia Pacific Erythropoietin Drug Market Outlook, By Epoetin-Alfa (2014-2022) ($MN)
Table 128 Asia Pacific Erythropoietin Drug Market Outlook, By Epoetin-Beta (2014-2022) ($MN)
Table 129 Asia Pacific Erythropoietin Drug Market Outlook, By Darbepoietin-Alfa (2014-2022) ($MN)
Table 130 Asia Pacific Erythropoietin Drug Market Outlook, By Other Biosimilar Products (2014-2022) ($MN)
Table 131 Asia Pacific Erythropoietin Drug Market Outlook, By Biologics (2014-2022) ($MN)
Table 132 Asia Pacific Erythropoietin Drug Market Outlook, By Epoetin-Zeta (2014-2022) ($MN)
Table 133 Asia Pacific Erythropoietin Drug Market Outlook, By Epoetin-Omega (2014-2022) ($MN)
Table 134 Asia Pacific Erythropoietin Drug Market Outlook, By Other Biologic Products (2014-2022) ($MN)
Table 135 Asia Pacific Erythropoietin Drug Market Outlook, By Drug (2014-2022) ($MN)
Table 136 Asia Pacific Erythropoietin Drug Market Outlook, By Biosimilar Drug (2014-2022) ($MN)
Table 137 Asia Pacific Erythropoietin Drug Market Outlook, By Xue Da Sheng (2014-2022) ($MN)
Table 138 Asia Pacific Erythropoietin Drug Market Outlook, By HEMAX (2014-2022) ($MN)
Table 139 Asia Pacific Erythropoietin Drug Market Outlook, By Abseamed (2014-2022) ($MN)
Table 140 Asia Pacific Erythropoietin Drug Market Outlook, By Retacrit (2014-2022) ($MN)
Table 141 Asia Pacific Erythropoietin Drug Market Outlook, By Epoetin-alfa BS (2014-2022) ($MN)
Table 142 Asia Pacific Erythropoietin Drug Market Outlook, By EPIAO (2014-2022) ($MN)
Table 143 Asia Pacific Erythropoietin Drug Market Outlook, By Binocrit (2014-2022) ($MN)
Table 144 Asia Pacific Erythropoietin Drug Market Outlook, By Other Biosimilar Drugs (2014-2022) ($MN)
Table 145 Asia Pacific Erythropoietin Drug Market Outlook, By Biologic Drug (2014-2022) ($MN)
Table 146 Asia Pacific Erythropoietin Drug Market Outlook, By Aranesp (2014-2022) ($MN)
Table 147 Asia Pacific Erythropoietin Drug Market Outlook, By Mircera (2014-2022) ($MN)
Table 148 Asia Pacific Erythropoietin Drug Market Outlook, By Procrit (2014-2022) ($MN)
Table 149 Asia Pacific Erythropoietin Drug Market Outlook, By NeoRecromon (2014-2022) ($MN)
Table 150 Asia Pacific Erythropoietin Drug Market Outlook, By Eprex (2014-2022) ($MN)
Table 151 Asia Pacific Erythropoietin Drug Market Outlook, By Epogen (2014-2022) ($MN)
Table 152 Asia Pacific Erythropoietin Drug Market Outlook, By Other Biologic Durgs (2014-2022) ($MN)
Table 153 Asia Pacific Erythropoietin Drug Market Outlook, By Application (2014-2022) ($MN)
Table 154 Asia Pacific Erythropoietin Drug Market Outlook, By Anemia (2014-2022) ($MN)
Table 155 Asia Pacific Erythropoietin Drug Market Outlook, By HIV (2014-2022) ($MN)
Table 156 Asia Pacific Erythropoietin Drug Market Outlook, By End Stage Renal Disease (2014-2022) ($MN)
Table 157 Asia Pacific Erythropoietin Drug Market Outlook, By Cancer (2014-2022) ($MN)
Table 158 Asia Pacific Erythropoietin Drug Market Outlook, By Dialysis (2014-2022) ($MN)
Table 159 Asia Pacific Erythropoietin Drug Market Outlook, By Oncology Diseases (2014-2022) ($MN)
Table 160 Asia Pacific Erythropoietin Drug Market Outlook, By Other Applications (2014-2022) ($MN)
Table 161 Asia Pacific Erythropoietin Drug Market Outlook, By End User (2014-2022) ($MN)
Table 162 Asia Pacific Erythropoietin Drug Market Outlook, By Retail Pharmacies (2014-2022) ($MN)
Table 163 Asia Pacific Erythropoietin Drug Market Outlook, By Hospital (2014-2022) ($MN)
Table 164 Asia Pacific Erythropoietin Drug Market Outlook, By Other End Users (2014-2022) ($MN)
Table 165 RoW Erythropoietin Drug Market Outlook, By Country (2014-2022) ($MN)
Table 166 RoW Erythropoietin Drug Market Outlook, By Product (2014-2022) ($MN)
Table 167 RoW Erythropoietin Drug Market Outlook, By Biosimilars (2014-2022) ($MN)
Table 168 RoW Erythropoietin Drug Market Outlook, By Epoetin-Alfa (2014-2022) ($MN)
Table 169 RoW Erythropoietin Drug Market Outlook, By Epoetin-Beta (2014-2022) ($MN)
Table 170 RoW Erythropoietin Drug Market Outlook, By Darbepoietin-Alfa (2014-2022) ($MN)
Table 171 RoW Erythropoietin Drug Market Outlook, By Other Biosimilar Products (2014-2022) ($MN)
Table 172 RoW Erythropoietin Drug Market Outlook, By Biologics (2014-2022) ($MN)
Table 173 RoW Erythropoietin Drug Market Outlook, By Epoetin-Zeta (2014-2022) ($MN)
Table 174 RoW Erythropoietin Drug Market Outlook, By Epoetin-Omega (2014-2022) ($MN)
Table 175 RoW Erythropoietin Drug Market Outlook, By Other Biologic Products (2014-2022) ($MN)
Table 176 RoW Erythropoietin Drug Market Outlook, By Drug (2014-2022) ($MN)
Table 177 RoW Erythropoietin Drug Market Outlook, By Biosimilar Drug (2014-2022) ($MN)
Table 178 RoW Erythropoietin Drug Market Outlook, By Xue Da Sheng (2014-2022) ($MN)
Table 179 RoW Erythropoietin Drug Market Outlook, By HEMAX (2014-2022) ($MN)
Table 180 RoW Erythropoietin Drug Market Outlook, By Abseamed (2014-2022) ($MN)
Table 181 RoW Erythropoietin Drug Market Outlook, By Retacrit (2014-2022) ($MN)
Table 182 RoW Erythropoietin Drug Market Outlook, By Epoetin-alfa BS (2014-2022) ($MN)
Table 183 RoW Erythropoietin Drug Market Outlook, By EPIAO (2014-2022) ($MN)
Table 184 RoW Erythropoietin Drug Market Outlook, By Binocrit (2014-2022) ($MN)
Table 185 RoW Erythropoietin Drug Market Outlook, By Other Biosimilar Drugs (2014-2022) ($MN)
Table 186 RoW Erythropoietin Drug Market Outlook, By Biologic Drug (2014-2022) ($MN)
Table 187 RoW Erythropoietin Drug Market Outlook, By Aranesp (2014-2022) ($MN)
Table 188 RoW Erythropoietin Drug Market Outlook, By Mircera (2014-2022) ($MN)
Table 189 RoW Erythropoietin Drug Market Outlook, By Procrit (2014-2022) ($MN)
Table 190 RoW Erythropoietin Drug Market Outlook, By NeoRecromon (2014-2022) ($MN)
Table 191 RoW Erythropoietin Drug Market Outlook, By Eprex (2014-2022) ($MN)
Table 192 RoW Erythropoietin Drug Market Outlook, By Epogen (2014-2022) ($MN)
Table 193 RoW Erythropoietin Drug Market Outlook, By Other Biologic Durgs (2014-2022) ($MN)
Table 194 RoW Erythropoietin Drug Market Outlook, By Application (2014-2022) ($MN)
Table 195 RoW Erythropoietin Drug Market Outlook, By Anemia (2014-2022) ($MN)
Table 196 RoW Erythropoietin Drug Market Outlook, By HIV (2014-2022) ($MN)
Table 197 RoW Erythropoietin Drug Market Outlook, By End Stage Renal Disease (2014-2022) ($MN)
Table 198 RoW Erythropoietin Drug Market Outlook, By Cancer (2014-2022) ($MN)
Table 199 RoW Erythropoietin Drug Market Outlook, By Dialysis (2014-2022) ($MN)
Table 200 RoW Erythropoietin Drug Market Outlook, By Oncology Diseases (2014-2022) ($MN)
Table 201 RoW Erythropoietin Drug Market Outlook, By Other Applications (2014-2022) ($MN)
Table 202 RoW Erythropoietin Drug Market Outlook, By End User (2014-2022) ($MN)
Table 203 RoW Erythropoietin Drug Market Outlook, By Retail Pharmacies (2014-2022) ($MN)
Table 204 RoW Erythropoietin Drug Market Outlook, By Hospital (2014-2022) ($MN)
Table 205 RoW Erythropoietin Drug Market Outlook, By Other End Users (2014-2022) ($MN)



★調査レポート[エリスロポエチン製剤の世界市場] (コード:SMRC70523041)販売に関する免責事項を必ずご確認ください。
★調査レポート[エリスロポエチン製剤の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆